FLAVONE is a lipid of Polyketides (PK) class. Flavone is associated with abnormalities such as Cardiovascular Diseases, Cerebrovascular accident, DERMATITIS HERPETIFORMIS, FAMILIAL, Hyperinsulinism and Inflammatory disorder. The involved functions are known as Oxidation-Reduction, Metabolic Inhibition, Inflammation, Phosphorylation and antioxidant activity. Flavone often locates in Endothelium, Hepatic, Protoplasm, Body tissue and Extracellular. The associated genes with FLAVONE are ICAM1 gene, BCL2L1 gene, MYC gene, TP53 gene and cytochrome c''. The related lipids are Promega, Steroids and Total cholesterol. The related experimental models are Knock-out, Disease model and Animal Disease Models.
To understand associated biological information of FLAVONE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
FLAVONE is suspected in Diabetes Mellitus, Non-Insulin-Dependent, Obesity, Chronic Disease, Disintegration, Cardiovascular Diseases, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with FLAVONE
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011) and Knock-out are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Disease model are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Animal Disease Models are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kim SY et al. | Cis-2', 3'-dihydrodiol production on flavone B-ring by biphenyl dioxygenase from Pseudomonas pseudoalcaligenes KF707 expressed in Escherichia coli. | 2003 | Antonie Van Leeuwenhoek | pmid:14574103 |
Lee S et al. | Solubility enhancement of a hydrophobic flavonoid, luteolin by the complexation with cyclosophoraoses isolated from Rhizobium meliloti. | 2003 | Antonie Van Leeuwenhoek | pmid:14574115 |
Carrara M et al. | Mono- or di-fluorinated analogues of flavone-8-acetic acid: synthesis and in vitro biological activity. | 2005 Mar-Apr | Anticancer Res. | pmid:15868960 |
Desoize B et al. | Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975). | 1989 Nov-Dec | Anticancer Res. | pmid:2627123 |
Harris SR et al. | Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells. | 2000 Jul-Aug | Anticancer Res. | pmid:10953282 |
Shao ZM et al. | Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. | 2000 Jul-Aug | Anticancer Res. | pmid:10953303 |
Chou ST et al. | Zanthoxylum ailanthoides Sieb and Zucc. extract inhibits growth and induces cell death through G2/M-phase arrest and activation of apoptotic signals in colo 205 human colon adenocarcinoma cells. | 2011 | Anticancer Res. | pmid:21617225 |
Valenti P et al. | Benzo-gamma-pyrone analogues of geiparvarin: synthesis and biological evaluation against B16 melanoma cells. | 1993 | Anticancer Drug Des. | pmid:8251042 |
Atwell GJ et al. | Synthesis and anti-tumour activity of topologically-related analogues of flavoneacetic acid. | 1989 | Anticancer Drug Des. | pmid:2803464 |
Spatafora C and Tringali C | Natural-derived polyphenols as potential anticancer agents. | 2012 | Anticancer Agents Med Chem | pmid:22292766 |
Aklilu M et al. | Phase II study of flavopiridol in patients with advanced colorectal cancer. | 2003 | Ann. Oncol. | pmid:12881391 |
Meyer H et al. | Bioavailability of apigenin from apiin-rich parsley in humans. | 2006 | Ann. Nutr. Metab. | pmid:16407641 |
Kim MJ et al. | Jaceosidin induces apoptosis in ras-transformed human breast epithelial cells through generation of reactive oxygen species. | 2007 | Ann. N. Y. Acad. Sci. | pmid:17404061 |
Lee E et al. | Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. | 2009 | Ann. N. Y. Acad. Sci. | pmid:19723047 |
Jeong MA et al. | Jaceosidin, a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells. | 2007 | Ann. N. Y. Acad. Sci. | pmid:17404058 |
Enomoto R et al. | Wogonin prevents immunosuppressive action but not anti-inflammatory effect induced by glucocorticoid. | 2007 | Ann. N. Y. Acad. Sci. | pmid:17404053 |
Lee E et al. | Wogonin, a plant flavone, potentiates etoposide-induced apoptosis in cancer cells. | 2007 | Ann. N. Y. Acad. Sci. | pmid:17404065 |
Bastos ML et al. | Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents. | 2009 | Ann. Clin. Microbiol. Antimicrob. | pmid:19450272 |
Gupta PJ and Kalaskar S | Ligation and mucopexy for prolapsing hemorrhoids--a ten year experience. | 2008 | Ann Surg Innov Res | pmid:19038061 |
Rudek MA et al. | Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. | 2003 | Ann Pharmacother | pmid:14519054 |